Our analysis revealed that our major targets, including AKT1, EGFR, TNF, and ALB, are significantly involved in HCC resistance pathways, which suggests that targeting these genes may disturb the pathways that lead to HCC [46]. Here, ALB is linked to hepatocellular carcinoma.